An emergency physician praises The Pitt’s second season for realistically portraying ER teamwork, human connection, and crisis response despite dramatic compression of events. mdsc.pe/4xi9zhD

Unlock insights into emerging clinical evidence, individualized treatment planning, and effective multi specialty collaboration to support patients at every stage of care. x.com/i/broadcasts/1NxarregQ…

Personal trainer Vanessa de Oliveira Victório spent 9 years seeking a diagnosis as intense cramps, chronic pain, fatigue, and anemia forced her to abandon her career. Dismissed by multiple doctors in Brazil's public and private systems, she was repeatedly told nothing was wrong. Surgery in 2021 finally revealed endometriosis, adenomyosis, and pelvic adhesions — but pain persisted through a second procedure in 2022. Her experience reflects a revaluation of clinical practice. In March, the American College of Obstetricians and Gynecologists released new guidelines allowing endometriosis to be diagnosed based on symptoms and physical exam alone, without surgical confirmation — a significant shift that centers pain as the starting point for treatment. mdsc.pe/43nAXx9

The US FDA today added bemotrizinol to the list of permitted sunscreen active ingredients, marking a significant moment in the agency’s efforts to advance sunscreen innovation. Bemotrizinol is the first new active ingredient added to the over-the-counter (OTC) sunscreen monograph since 1999. Bemotrizinol protects against both ultraviolet A and B rays and has low absorption through the skin into the body, according to the FDA announcement on June 9. The agency considers bemotrizinol generally recognized as safe and effective for sunscreen use by adults and children 6 months and older. Bemotrizinol has been used in Europe and other regions for years. mdsc.pe/4xzIEhA

Publishing scientific articles is often viewed as a requirement in medicine. Scientific output remains one of the main indicators of professional performance for researchers and physicians affiliated with academic institutions. For frontline clinicians, however, publishing may be less of a requirement and more of an opportunity to strengthen critical appraisal skills, a core component of evidence-based medical practice. The impact factor of a journal often carries considerable weight and is often regarded as a marker of prestige. However, experts have cautioned that it should not be the sole criterion used to evaluate scientific literature or select a journal for manuscript submission. mdsc.pe/4vGSCMn

Join us for a Hybrid 👥 Event! 🥼 Hematologist, Oncologist, Pediatricians, EM specialists, NPs, PAs, Nurses and Pharmacists. 🌟 Learners to be better able to assess treatment success beyond bleeding rates, to differentiate clinically meaningful features of available therapies, to integrate patient goals into treatment selection, and to implement team-based workflows that support coordinated management and improved outcomes. 🔗 mdsc.pe/4uYuepy

When the first messenger RNA (mRNA) vaccines proved effective during COVID, many experts viewed them as a short-term fix. Five years later, the same technology evolved into one of medicine’s most ambitious platforms, with applications now spanning cancer, rare diseases, and chronic conditions that were once considered out of reach. Currently, mRNA extends well beyond the prevention of infectious diseases. Recent clinical trials have demonstrated potential in oncology, rare diseases, and personalized medicine, establishing it as one of the most active areas of biomedical innovation. Important challenges remain, including improving stability, targeting specific tissues, and extending the duration of therapeutic effects. mdsc.pe/4e8gh13

Both recreational use and unintentional exposure to marijuana vs other substances increased in the US from 2015 to 2021, especially in adolescents and children, a new survey showed. However, fewer major adverse events (AEs) and deaths occurred from the use of marijuana alone compared with the use of most licit and illicit substances. mdsc.pe/4uvKqNQ

Yet another large database study is tying GLP-1 drugs to potential benefits in cancer, suggesting that some patients prescribed the medications after cancer diagnosis have a significantly decreased rate of progression to metastatic disease. The study examined real-world data from over 12,000 patients with any of seven cancers associated with obesity, diabetes, or both. It found that among patients with four of those cancers — lung, breast, colorectal, or liver — those prescribed a GLP-1 medication were 38%-50% less likely to progress to stage IV disease than comparable patients prescribed a gliptin diabetes medication. The findings, presented at the American Society of Clinical Oncology (ASCO) 2026, add to a growing body of evidence linking GLP-1 use to either reduced cancer incidence or improved cancer outcomes. mdsc.pe/4uYn1FI

Hair & scalp disorders remain some of the most common—and complex—conditions in dermatology. Join leading experts for Hair & Scalp Disorders: The Rx Pad & Beyond, at this virtual CME conference focused on practical, evidence-based strategies you can apply immediately in clinical practice. hairscalpdisorders.com #HairScalpRxPB

Robotic mitral valve repair achieved excellent long-term durability and shortened ICU and hospital stays compared with endoscopic surgery. mdsc.pe/4vFE0ge

ctDNA tests can predict cancer relapse, but their role in guiding treatment remains uncertain. While ctDNA positivity indicates higher recurrence risk, evidence on improving outcomes through early intervention is limited, posing a dilemma for oncologists. mdsc.pe/4eiqB6J

In adults with type 2 diabetes (T2D) and overweight receiving insulin therapy, acupuncture reduced the daily insulin dose by about 13% compared with a sham treatment. A 3-month protocol resulted in a mean reduction of 5.3 IU in total daily insulin needs, indicating a possible insulin-sensitizing effect. mdsc.pe/4uyrZbl

Researchers are exploring ways to reverse cellular aging, with promising advancements in epigenetic restoration and metabolic interventions. Human trials are underway, but exercise remains a proven, cost-effective method to enhance cellular health. mdsc.pe/4eDbt50

💻 Virtual Event! 🥼 Neurologists, Neuroradiologists, PCPs, Geriatricians, Psychiatrists, NPs, PAs, and Nurses. 🧠 Learners will be better able to summarize recent data on the use of AATs for early stages of AD and select and monitor patients receiving an AAT for the management of early stages of AD. 👉 events.medscapelive.org/webs…

Stem cell transplants show promise in controlling multiple sclerosis (MS) long-term, with some patients experiencing no relapses or need for medication. While not universally successful, it's now considered a valid option for select patients. mdsc.pe/4uuKUDS

How are the latest targeted therapies shifting how you approach early-stage IDH-mutant glioma? Explore the new era of glioma management and get expert strategies for timing therapies and tailoring your patient approach. Read here: mdsc.pe/4uF9m6u

Are your IgA Nephropathy patients missing early signs? Dr. Shikha Wadhwani and patient John Marsala discuss the critical reality of early diagnosis, routine urine checks, and navigating a lifelong kidney disease. Watch the full discussion ➡️ mdsc.pe/3QhuvEI #IgANephropathy #Nephrology #CME

Evidence of amyloid and tau pathology was associated with worse cognitive performance and accelerated cognitive decline in midlife adults without dementia, a new cohort study showed. Positivity for the Alzheimer’s disease (AD) blood biomarkers was rare, reported in only 6%-15% of participants. However, the cognitive impacts were significant, with lower performance in processing speed and executive function and a faster decline in verbal memory and processing speed over 5 years than those without biomarker-defined AD neuropathology. mdsc.pe/3S7AnB4

New content available – CAR T cells in autoimmune rheumatic disease: learn how deep B‑cell depletion may enable drug‑free remission, review early case data, and practical guidance on selecting and comanaging patients across specialties. ▶️ mdsc.pe/4wIFo2J